Cronos CRON stock analysis and how Cronos CRON stock gets to profitability

LOUISVILLE, Ky. — More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug combination, which held disease progression at

A vouch­er pro­gram de­signed to stim­u­late drug de­vel­op­ment for rare pe­di­atric dis­eases will sun­set lat­er this year if law­mak­ers don’t reau­tho­rize it — and rare